Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004979375 | SCV005567758 | uncertain significance | Inborn genetic diseases | 2024-09-03 | criteria provided, single submitter | clinical testing | The c.3197A>G (p.N1066S) alteration is located in exon 23 (coding exon 23) of the CUBN gene. This alteration results from a A to G substitution at nucleotide position 3197, causing the asparagine (N) at amino acid position 1066 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038892 | SCV005669134 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2024-06-04 | criteria provided, single submitter | clinical testing |